Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 3/20 | 0.68 |
| ▸ | NPC1 | O15118 | 4/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | GAPDH | P04406 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | MIF | P14174 | 9/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | GLA | P06280 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2168286 | 0.85 | NPC1 (0.66) | NPC1RAB9AALDH1A1HPGDGAA | |
| SCHEMBL2166723 | 0.81 | ESR2 (1.00) | ESR2NPC1RAB9AALDH1A1HPGD | |
| SCHEMBL18523587 | 0.81 | ESR2 (0.67) | ESR2NPC1RAB9AALDH1A1HPGD | |
| SCHEMBL25853393 | 0.80 | ESR2 (0.65) | ESR2NPC1RAB9AALDH1A1HPGD | |
| SCHEMBL23316808 | 0.78 | ESR2 (0.76) | ESR2NPC1RAB9AALDH1A1HPGD | |
| SCHEMBL15068480 | 0.78 | MIF (0.46) | ESR2NPC1RAB9AALDH1A1HPGD | |
| SCHEMBL15066651 | 0.78 | AKR1B10 (0.41) | ESR2NPC1L3MBTL1MIFPOLB | |
| SCHEMBL11297212 | 0.77 | ADORA3 (0.51) | ESR2NPC1RAB9AALDH1A1HPGD | |
| SCHEMBL16520509 | 0.76 | MIF (0.83) | ESR2NPC1RAB9AALDH1A1HPGD | |
| SCHEMBL802632 | 0.75 | ESR2 (0.56) | ESR2NPC1RAB9AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102197109-B | Liquid crystal display | MERCK PATENT GMBH | 2014-05-14 | — | — | CN | disclosed |
| US-8592007-B2 | Liquid-crystal display | MERCK PATENT GMBH (DE) | 2013-11-26 | — | — | US | disclosed |
| EP-2340292-B1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2013-05-29 | — | — | EP | disclosed |
| EP-2340292-B1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2013-05-29 | — | — | EP | disclosed |
| CN-102197109-A | Liquid crystal display | MERCK PATENT GMBH | 2011-09-21 | — | — | CN | disclosed |
| US-20110205482-A1 | LIQUID-CRYSTAL DISPLAY | MERCH PATENT GESELLSCHAFT MIT BESCHRANKTE HAFTUNG (DE) | 2011-08-25 | — | — | US | disclosed |
| US-20110205482-A1 | LIQUID-CRYSTAL DISPLAY | MERCH PATENT GESELLSCHAFT MIT BESCHRANKTE HAFTUNG (DE) | 2011-08-25 | — | — | US | disclosed |
| US-20110205482-A1 | LIQUID-CRYSTAL DISPLAY | MERCH PATENT GESELLSCHAFT MIT BESCHRANKTE HAFTUNG (DE) | 2011-08-25 | — | — | US | disclosed |
| EP-2340292-A1 | LIQUID CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2011-07-06 | — | — | EP | disclosed |
| WO-2010049044-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010049044-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2010-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110205482-A1 | LIQUID-CRYSTAL DISPLAY | VCL, LPXN, LCP1 | ESR2 2890/4885NPC1 4181/4885RAB9A 2121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.